Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Gomariz

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Neuropeptides|December 1, 1996
Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobilityE Garrido, M Delgado, C Martínez, et al.
Journal of Neuroimmunology|June 23, 1999
Regulation of VIP production and secretion by murine lymphocytesC Martinez, M Delgado, C Abad, et al.
Neuroimmunomodulation|August 1, 2008
Vasoactive intestinal peptide as a healing mediator in Crohn's diseaseA Arranz, C Abad, Y Juarranz, et al.
Clinical and Experimental Immunology|November 22, 2005
Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitisF Rosignoli, V Roca, R Meiss, et al.
Biochimica Et Biophysica Acta|January 20, 1998
Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophagesD Pozo, M Delgado, C Martinez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6M Delgado, C Martinez, D Pozo, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 28, 2002
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseasesM Delgado, C Abad, C Martinez, et al.
Regulatory Peptides|November 3, 1993
Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat macrophages. Protein kinase C involvementM De la Fuente, M Delgado, M del Rio, et al.
Regulatory Peptides|April 23, 1996
Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophagesM Delgado, D Pozo, C Martinez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studiesM Delgado, D Pozo, C Martinez, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Neuropeptides|December 1, 1996
Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobilityE Garrido, M Delgado, C Martínez, et al.
Journal of Neuroimmunology|June 23, 1999
Regulation of VIP production and secretion by murine lymphocytesC Martinez, M Delgado, C Abad, et al.
Neuroimmunomodulation|August 1, 2008
Vasoactive intestinal peptide as a healing mediator in Crohn's diseaseA Arranz, C Abad, Y Juarranz, et al.
Clinical and Experimental Immunology|November 22, 2005
Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitisF Rosignoli, V Roca, R Meiss, et al.
Biochimica Et Biophysica Acta|January 20, 1998
Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophagesD Pozo, M Delgado, C Martinez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6M Delgado, C Martinez, D Pozo, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 28, 2002
Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseasesM Delgado, C Abad, C Martinez, et al.
Regulatory Peptides|November 3, 1993
Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat macrophages. Protein kinase C involvementM De la Fuente, M Delgado, M del Rio, et al.
Regulatory Peptides|April 23, 1996
Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophagesM Delgado, D Pozo, C Martinez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studiesM Delgado, D Pozo, C Martinez, et al.
Pageof 6